Medical Condition News

RSS

Sleep apnea can favor lung cancer growth in young individuals

A scientific study, conducted with animal models, states that sleep apnea can favor lung cancer growth in young individuals. Thus, aging would be a protecting factor against the fast tumor development, induced by this sleep alteration.

12 Sep 2018

New test to predict advanced fibrosis in people with NAFLD

A new test may soon be available to predict advanced fibrosis in people with non-alcoholic fatty liver disease.

12 Sep 2018

Cocaine-addicted rats show long-lasting increases in number of orexin neurons

A study in cocaine-addicted rats reports long-lasting increases in the number of neurons that produce orexin—a chemical messenger important for sleep and appetite—that may be at the root of the addiction.

12 Sep 2018

New dopamine sensors could improve our understanding of Parkinson’s Disease

Researchers have developed a sensor that can measure dopamine in the brain for more than a year. The tech could help us understand Parkinson's and depression.

12 Sep 2018

Improving early-stage diagnosis of diseases linked to metabolic syndrome

An EU-funded network of universities, hospitals and pharmaceutical and life sciences companies is studying an inflammatory condition associated with a variety of diseases.

12 Sep 2018

Health Care Apps and the Empowered Patient

An interview with Evergreen Life, discussing the importance of patient empowerment and how technology is allowing the NHS take a holistic approach to care.

From Evergreen Life 12 Sep 2018

Research shows novel approach for treatment of myocardial infarction

Myocardial infarction - commonly known as a heart attack - is still one of the main causes of death. According to the Federal Statistical Office, more than 49,00 people died of its consequences.

12 Sep 2018

ADHD patients have increased risk of developing Parkinson's and other similar diseases

While about 11 percent of children (4-17 years old) nationwide have been diagnosed with attention-deficit hyperactivity disorder, the long-term health effects of having ADHD and of common ADHD medications remains understudied.

12 Sep 2018

Study uncovers four neuron types in the peripheral auditory system

Researchers at Karolinska Institutet have identified four types of neurons in the peripheral auditory system, three of which are new to science.

12 Sep 2018

Alivio Therapeutics receives DoD grant to advance development of new therapy for IC/BPS

Alivio Therapeutics, an affiliate of PureTech Health plc developing therapies to treat inflammatory disorders through targeted disease immunomodulation, today announced a $3.3 million U.S. Department of Defense Technology/Therapeutic Development Award to advance Alivio's product candidate, ALV-107, for the treatment of interstitial cystitis/bladder pain syndrome with Hunner's lesions.

12 Sep 2018

Researchers design new medicine to treat highly aggressive pancreatic cancer

A treatment for highly aggressive and commonly fatal pancreatic cancer is being developed, reports a University of Houston researcher who has designed a new medicine that can inhibit two of the major pathways of the deadly disease.

12 Sep 2018

Survey: Psoriasis patients expect treatment to go beyond just clear skin and safety

Novartis, a leader in immuno-dermatology, announced today new data from a patient preference survey showing psoriasis patients want their treatment to go beyond just clear skin and safety.

12 Sep 2018

Consuming more caffeine may help reduce risk of death for people with kidney disease

A new study in Nephrology Dialysis Transplantation indicates that consuming more caffeine may help reduce the risk of death for people with chronic kidney disease.

12 Sep 2018

New study links stress with biological disease markers in leukemia patients

Patients with chronic lymphocytic leukemia who feel more stress also have more cancer cells in their blood and elevated levels of three other markers of more advanced disease.

12 Sep 2018

Wake Forest Baptist receives federal grants to develop new treatments for neurological diseases

The National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health, has awarded Wake Forest Baptist Medical Center two five-year grants, each worth approximately $1.5 million, to participate in two nationwide clinical trial networks.

12 Sep 2018

Administering tPA depending on location of clot can be as effective as thrombectomy

There are two main treatments for stroke caused by a clot in a blood vessel in the brain. One treatment, mechanical thrombectomy, involves pulling the clot out with a specialized catheter that is inserted into the artery in the groin and guided by imaging to the clot.

12 Sep 2018

Scientists gain better understanding of tumor initiation and metastasis in colon cancer patients

Researchers from the University of Luxembourg have discovered a molecular mechanism that is responsible for the spread of cancer cells in the body and the development of metastases in patients with colon cancer. Their findings could help to develop treatments that inhibit tumor growth.

11 Sep 2018

Treating sleep apnea in stroke patients provides significant benefits

A large study has found that commencing treatment for sleep apnea as soon as possible after a stroke or a mini-stroke significantly improves speech impairment and other neurological symptoms as well as walking and other physical functioning.

11 Sep 2018

Inhaled form of high blood pressure drug has potential to treat anxiety, pain

An inhaled form of a high blood pressure medication has potential to treat certain types of anxiety as well as pain, according to a new study by the Centre for Addiction and Mental Health.

11 Sep 2018

ImmusanT receives JDRF T1D Fund to develop novel vaccine candidate for type 1 diabetes

ImmusanT, Inc., a clinical stage company that is leveraging its Epitope-Specific Immuno-Therapy™ platform to translate and deliver first-in-class peptide-based immune therapies to people living with autoimmune diseases, today announced that it has received an investment from the JDRF T1D Fund, a venture philanthropy fund exclusively devoted to finding and funding the best type 1 diabetes commercial opportunities.

11 Sep 2018

Medical Condition News

Sleep apnea can favor lung cancer growth in young individuals

New test to predict advanced fibrosis in people with NAFLD

Cocaine-addicted rats show long-lasting increases in number of orexin neurons

New dopamine sensors could improve our understanding of Parkinson’s Disease

Improving early-stage diagnosis of diseases linked to metabolic syndrome

Health Care Apps and the Empowered Patient

Research shows novel approach for treatment of myocardial infarction

ADHD patients have increased risk of developing Parkinson's and other similar diseases

Study uncovers four neuron types in the peripheral auditory system

Alivio Therapeutics receives DoD grant to advance development of new therapy for IC/BPS

Researchers design new medicine to treat highly aggressive pancreatic cancer

Survey: Psoriasis patients expect treatment to go beyond just clear skin and safety

Consuming more caffeine may help reduce risk of death for people with kidney disease

New study links stress with biological disease markers in leukemia patients

Wake Forest Baptist receives federal grants to develop new treatments for neurological diseases

Administering tPA depending on location of clot can be as effective as thrombectomy

Scientists gain better understanding of tumor initiation and metastasis in colon cancer patients

Treating sleep apnea in stroke patients provides significant benefits

Inhaled form of high blood pressure drug has potential to treat anxiety, pain

ImmusanT receives JDRF T1D Fund to develop novel vaccine candidate for type 1 diabetes

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News